Key statistics
On Wednesday, HUTCHMED (China) Ltd (H7T1:BER) closed at 12.60, 23.53% above the 52 week low of 10.20 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.60 |
---|---|
High | 12.60 |
Low | 12.60 |
Bid | 13.10 |
Offer | 13.40 |
Previous close | 12.20 |
Average volume | 398.90 |
---|---|
Shares outstanding | 174.42m |
Free float | 88.83m |
P/E (TTM) | 71.29 |
Market cap | 2.67bn USD |
EPS (TTM) | 0.2162 USD |
Data delayed at least 15 minutes, as of Jul 02 2025 07:08 BST.
More ▼
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
- HUTCHMED Highlights SACHI Phase III Data at ASCO
- HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting
- Total Voting Rights
More ▼